ROYAL BANK OF CANADA - ORCHARD THERAPEUTICS PLC ownership

ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 74 filers reported holding ORCHARD THERAPEUTICS PLC in Q4 2021. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ORCHARD THERAPEUTICS PLC
ValueSharesWeighting
Q4 2022$090.0%0.00%
Q3 2022$0
-100.0%
9
-99.6%
0.00%
Q2 2022$1,0002,009
+22222.2%
0.00%
Q1 2022$09
+12.5%
0.00%
Q4 2021$0
-100.0%
8
-99.9%
0.00%
Q3 2021$25,000
-43.2%
10,800
+8.0%
0.00%
Q2 2021$44,000
-42.9%
10,000
-4.8%
0.00%
Q1 2021$77,000
+79.1%
10,509
+5.1%
0.00%
Q4 2020$43,000
+2050.0%
10,000
+1660.6%
0.00%
Q3 2020$2,0005680.00%
Other shareholders
ORCHARD THERAPEUTICS PLC shareholders Q4 2021
NameSharesValueWeighting ↓
CHI Advisors LLC 5,307,751$3,101,0001.18%
TANG CAPITAL MANAGEMENT LLC 2,000,000$1,168,0000.18%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,949,416$4,060,0000.08%
Artal Group S.A. 1,803,858$1,054,0000.06%
GSA CAPITAL PARTNERS LLP 616,402$360,0000.05%
RA Capital Management 3,040,885$1,776,0000.05%
Forefront Analytics, LLC 92,641$58,0000.03%
Temasek Holdings (Private) Ltd 4,319,049$2,523,1880.01%
FEDERATED HERMES, INC. 8,309,859$4,853,0000.01%
Cormorant Asset Management, LP 256,649$150,0000.01%
View complete list of ORCHARD THERAPEUTICS PLC shareholders